Panacea Index Logo

Command Palette

Search for a command to run...

The Efficacy of Light Therapy in the Treatment of Seasonal Affective Disorder: A Meta-Analysis of Randomized Controlled Trials.

Psychotherapy and psychosomatics
January 1, 2020
Edda Pjrek et al. (9 authors)
Journal ArticleMeta-AnalysisHuman Study
Study Details

Study Goal

The researchers aimed to assess the efficacy of bright light therapy (BLT) in treating seasonal affective disorder (SAD) in adults by comparing it to dim light or placebo.

Results Summary

BLT was found to be superior to placebo, with a standardized mean difference of -0.37 for depression ratings and a risk ratio of 1.42 for treatment response, though the studies showed moderate heterogeneity and risk of bias.

Population

Adults with seasonal affective disorder (SAD).

Effective Dosage

Bright light therapy (≥1,000 lx) via light box or light visor.

Duration

Not specified in the abstract.

Interactions

None mentioned.

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Bright light therapy (BLT)
decrease
depression ratings
adults with seasonal affective disorder (SAD)
standardized mean difference of -0.37 (95% CI: -0.63 to -0.12)
was superior over placebo
#1
Bright light therapy (BLT)
increase
response to active treatment
adults with seasonal affective disorder (SAD)
risk ratio of 1.42 (95% CI: 1.08-1.85)
was superior over placebo
#2
Bright light therapy (BLT)
neutral
SAD
adults with seasonal affective disorder (SAD)
-
can be regarded as an effective treatment
#3
Abstract

BACKGROUND: Bright light therapy (BLT) has been used as a treatment for seasonal affective disorder (SAD) for over 30 years. This meta-analysis was aimed to assess the efficacy of BLT in the treatment of SAD in adults. METHOD: We performed a systematic literature search including randomized, single- or double-blind clinical trials investigating BLT (≥1,000 lx, light box or light visor) against dim light (≤400 lx) or sham/low-density negative ion generators as placebo. Only first-period data were used from crossover trials. The primary outcome was the post-treatment depression score measured by validated scales, and the secondary outcome was the rate of response to treatment. RESULTS: A total of 19 studies finally met our predefined inclusion criteria. BLT was superior over placebo with a standardized mean difference of -0.37 (95% CI: -0.63 to -0.12) for depression ratings (18 studies, 610 patients) and a risk ratio of 1.42 (95% CI: 1.08-1.85) for response to active treatment (16 studies, 559 patients). We found no evidence for a publication bias, but moderate heterogeneity of the studies and a moderate-to-high risk of bias. CONCLUSIONS: BLT can be regarded as an effective treatment for SAD, but the available evidence stems from methodologically heterogeneous studies with small-to-medium sample sizes, necessitating larger high-quality clinical trials.

Medical Subject Headings (MeSH)
AdultHumansPhototherapyPsychiatric Status Rating ScalesRandomized Controlled Trials as TopicSeasonal Affective DisorderTreatment Outcome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality70/10
Citation Metrics
Total Citations69
Citations/Year13.8
Relative Citation Ratio5.72
NIH Percentile94.4%
Research Impact Scores
APT Score0.95
Weight Score2.45
Normalized Score0.64
Related Supplements